✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Eli Lilly and Co

Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
47,000
Ticker
LLY
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Eli Lilly and Company is a leading pharmaceutical firm with a global reputation for developing and marketing innovative medicines. Founded in 1876 and headquartered in Indianapolis, Indiana, the compa...

Eli Lilly and Co's Financial Statements Preview

Below are the financial statements of Eli Lilly and Co, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of USD
2024
2023
2022
Revenue
45.04a
34.12a
28.54a
Costs, expenses, and other
Cost of sales
-8.42a
-7.08a
-6.63a
Research and development
-10.99a
-9.31a
-7.19a
Marketing, selling, and administrative
-8.59a
-7.4a
-6.44a
Acquired in-process research and development
-3.28a
-3.8a
-0.91a
Asset impairment, restructuring, and other special charges
-0.86a
-0.07a
-0.24a
Other - net, (income) expense
0.22a
-0.1a
0.32a
Income before income taxes
12.68a
6.55a
6.81a
Income taxes
-2.09a
-1.31a
-0.56a
Net income
10.59a
5.24a
6.24a
Limited Data Preview
You are viewing a limited preview of Eli Lilly and Co’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Eli Lilly and Co’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eli Lilly and Co’s data sources below and access millions more through our Disclosure Search.

a. Eli Lilly and Co's Annual Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?